Xencor | LinkedIn (original) (raw)

About us

Proteins by Design Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. At Xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics – antibodies that target new biological mechanisms and are more potent, safer and longer lasting – to improve patient outcomes and quality of life. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance. The XmAb® platform has resulted in a robust pipeline of antibody product candidates, including eight in human clinical trials being developed by Xencor and by pharmaceutical partners. Xencor is also discovering biologics products that improve the performance of old antibody drugs, known as biosuperiors, to benefit patients, ease compliance and help reduce costs.

Industry

Biotechnology

Company size

201-500 employees

Headquarters

Pasadena, California

Type

Public Company

Founded

1997

Specialties

Protein engineering, Drug development, Antibody drugs, Biotechnology, Oncology, Autoimmune disease, Bispecific antibodies, and Cytokines

Locations

Employees at Xencor

Updates

Our President & CEO Bassil Dahiyat, Ph.D. will participate in the #FierceJPMWeek panel discussion The Future of Oncology: Key Investment Areas and Advancements in Treatment Methodologies. At #JPM25? Join us at Hyatt Regency Embarcadero on Tuesday, January 14 to hear Bassil and other panelists discuss trends and what’s to come in #oncology R&D. See the panel details and register here: https://bit.ly/4g9qg64 Fierce Biotech
We're #hiring a new Director, Analytical Sciences in San Diego, California. Apply today or share this post with your network.
We're #hiring a new Temporary Contractor- Contracts Analyst/Manager in San Diego, California. Apply today or share this post with your network.
We're #hiring a new Sr. Manager, Facilities & Engineering in Pasadena, California. Apply today or share this post with your network.
We're #hiring a new Director, CMC Regulatory Affairs in San Diego, California. Apply today or share this post with your network.
"Xencor is developing experimental drugs based on world-class #proteinengineering technology, and science has always been the core of what we do. We are privileged to keep this focus because we have an incredible technical, scientific and business talent base right here in the #LosAngeles region. The diversity and scale of our economy and our people will be the edge that LA has, and as the #biotech ecosystem in LA continues to grow, more people will recognize that." Bassil Dahiyat, President and CEO
Founded in 1997 as a Caltech spinout, Xencor has been a trailblazer in LA’s biotech revolution. With its XmAb protein engineering platform, the company is transforming antibody drug development, advancing more than 20 clinical programs in oncology and immunology. Learn how Xencor is shaping the future of biotech, with the region’s vibrant diversity at the heart of its life-changing innovations. Learn more: https://bit.ly/4fU6gUF #YourStoryIsOurStory
We're #hiring a new Medical Director, Clinical Development-Rheumatology in United States. Apply today or share this post with your network.
We're #hiring a new Medical Director, Clinical Development-Rheumatology in United States. Apply today or share this post with your network.
We're #hiring a new Sr. Manager, Facilities & Engineering in Pasadena, California. Apply today or share this post with your network.

Join now to see what you are missing

Join now

Xencor | LinkedIn (original) (raw)

About us

Locations

Employees at Xencor

Updates

Join now to see what you are missing

Similar pages

Browse jobs

Funding